Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Benderly

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Harefuah|January 22, 2010
[How to plan a controlled clinical trial?]M Benderly, G Chodick, Y Lerman
The American Journal of Cardiology|December 1, 1996
Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Israeli BIP Study GroupD Harpaz, M Benderly, U Goldbourt, et al.
American Journal of Epidemiology|July 15, 1997
Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine TrialM Benderly, S Behar, H Reicher-Reiss, et al.
European Journal of Neurology|December 6, 2011
Off-hours admission for acute stroke is not associated with worse outcome--a nationwide Israeli stroke projectJ Y Streifler, M Benderly, N Molshatzki, et al.
Cardiology|October 12, 1999
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-upE Z Fisman, A Tenenbaum, M Benderly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study GroupM Benderly, E Graff, H Reicher-Reiss, et al.
Circulation|August 3, 1999
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) RegistryM Haim, M Benderly, D Brunner, et al.
European Heart Journal|January 1, 1997
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study GroupS Behar, E Graff, H Reicher-Reiss, et al.
The American Journal of Cardiology|June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study GroupM Haim, A Shotan, V Boyko, et al.
Cardiology|February 7, 2007
C-reactive protein distribution and correlates among men and women with chronic coronary heart diseaseM Benderly, M Haim, V Boyko, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Harefuah|January 22, 2010
[How to plan a controlled clinical trial?]M Benderly, G Chodick, Y Lerman
The American Journal of Cardiology|December 1, 1996
Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Israeli BIP Study GroupD Harpaz, M Benderly, U Goldbourt, et al.
American Journal of Epidemiology|July 15, 1997
Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine TrialM Benderly, S Behar, H Reicher-Reiss, et al.
European Journal of Neurology|December 6, 2011
Off-hours admission for acute stroke is not associated with worse outcome--a nationwide Israeli stroke projectJ Y Streifler, M Benderly, N Molshatzki, et al.
Cardiology|October 12, 1999
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-upE Z Fisman, A Tenenbaum, M Benderly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study GroupM Benderly, E Graff, H Reicher-Reiss, et al.
Circulation|August 3, 1999
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) RegistryM Haim, M Benderly, D Brunner, et al.
European Heart Journal|January 1, 1997
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study GroupS Behar, E Graff, H Reicher-Reiss, et al.
The American Journal of Cardiology|June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study GroupM Haim, A Shotan, V Boyko, et al.
Cardiology|February 7, 2007
C-reactive protein distribution and correlates among men and women with chronic coronary heart diseaseM Benderly, M Haim, V Boyko, et al.
Pageof 2